Licenciada em Medicina Veterinária pelo Instituto de Ciências Biomédicas de Abel Salazar (ICBAS) da Universidade do Porto (2007). Doutorada em Ciências Veterinárias pelo ICBAS na área da oncologia (2012). Professora auxiliar na Faculdade de Medicina Veterinária da Universidade Lusófona de Humanidades e Tecnologias (FMV-ULHT), em Lisboa (2013-2017). Responsável pelo serviço de oncologia do hospital escolar da FMV-ULHT (2013-2017). Professora auxiliar na Escola de Ciências e Tecnologias da Universidade de Évora (2018). Professora auxiliar do departamento de Clínicas Veterinárias do ICBAS (2019 até à data). Afiliação como investigadora no CECA-ICETA (desde 2015). Realizou formação em medicina interna e em oncologia veterinária na Universidade do Tennessee-USA (2005-2006), na Universidade de WisconsinMadison - USA (2011) e no Royal Veterinary College-UK (2014). Autora de várias publicações em revistas científicas veterinárias internacionais e palestrante convidada em vários congressos e cursos na área da oncologia.

Artigos Científicos em Revistas Indexadas (SCI)

 

1- Santos, A., Lopes, C., Marques, R. M., Amorim, I., Ribeiro, J., Frias, C., Vicente, C., Gärtner, Matos, A. (2011). Immunohistochemical analysis of urokinase plasminogen activator and its prognostic value in canine mammary tumours. The Veterinary Journal 189: 43-48. doi: 10.1016/j.tvjl.2010.05.02

2- Santos A., Oliveira JT, Lopes CC, Amorim, IF, Vicente, CM, Gärtner FR, Matos, AJ (2010). Immunohistochemical expression of VEGF in Canine Mammary Tumours. Journal Comparative Pathology 143(4): 268-75. doi: 10.1016/j.jcpa.2010.04.006

 3- Santos, A., Lopes, C., Frias, C., Amorim, I., Vicente. C., Gärtner, F., Matos, A. (2011) Immunohistochemical evaluation of MMP-2 and TIMP-2 in canine mammary tumours: A survival study. The Veterinary Journal 190, 396-402.doi: 10.1016/j.tvjl.2010.12.003

4- Santos, A. A.; Lopes, C. C.; Marques, R. R.; Amorim, I. F.; Gärtner, M. F., Matos, A.J.F. (2012). Matrix Metalloproteinase-9 expression in mammary gland tumors in dogs and its relationship with prognostic factos and patient outcome. American Journal of Veterinary Research 73, 689-697. doi: 10.2460/ajvr.73.5.689

5- Santos, A., Lopes, C. C., Ribeiro, J. R., Martins, L. R., Santos, J. C., Amorim, I. F., Gärtner, F., Matos, A. J. (2013). Identification of prognostic factors in canine mammary malignant tumours: a multivariable survival study. BMC Veterinary Research 9:1. doi: 10.1186/1746-6148-9-1.

6- Santos, A., Lopes, C., Gärtner, F., Matos, A.J.F, 2014. VEGFR-2 expression in malignant tumours of the canine mammary gland: A prospective survival study. Veterinary Comparative Oncology. doi: 10.1111/vco.12107

7 - Santos, M., Correia-Gomes, C., Santos, A., Matos, A., Rocha, E., Lopes, C., Dias Pereira, P. (2014). Nuclear Polimorphism: Role in grading and prognosis of canine mammary carcinomas. The Veterinary Journal 200, 426-433. doi: 10.1016/j.tvjl.2014.03.019

8 - Santos, M., Correia-Gomes, C., Marcos, R., Santos, A., Matos, A., Lopes, C., Dias Pereira, P. (2015). Value of Nottingham Histological Grading Parameters and Nottingham Prognostic Index in Canine Mammary Carcinoma. Anticancer Research 35, 4219-4228. PMID: 26124382

9 - Santos, M., Correia-Gomes, C., Santos, A., Matos, A., Dias Pereira, P.,  Lopes, C. (2015). Interobserver Reproducibility of Histological Grading of Canine Simple Mammary Carcinomas. Journal Comparative Pathology 153, 22-27. doi: 10.1016/j.jcpa.2015.04.005

10 - Matos, A.J.F., Santos, A. (2015). Advances in the understanding of the clinically relevant genetic pathways and molecular aspects of canine mammary tumours: Part 1. Proliferation, apoptosis and DNA repair. The Veterinary Journal 205, 136-143. doi: 10.1016/j.tvjl.2015.02.004

11 - Santos, A., Matos, A.J.F. (2015). Advances in the understanding of the clinically relevant genetic pathways and molecular aspects of canine mammary tumours. Part 2: Invasion, angiogenesis, metastasis and therapy. The Veterinary Journal 205, 144-153. doi: 10.1016/j.tvjl.2015.03.029

12 - Ramos, S.C., Matos, A.J.F., Ribeiro, J.N, Leite-Martins, L.R., Ferreira, R.R.F., Viegas, I., Santos, A. (2017). Serum levels of urokinase-type plasminogen activator n healthy dogs and in oncologic canine patients. Veterinary World 10 (8), 918-923.

13 – Viegas, C., Matos, A.J.F., Leite-Martins, L.R., Viegas, I., Ferreira, R.R.F., Gregório, H., Santos, A. (2020). Determination of urokinase-type plasminogen activator serum levels in healthy and oncologic cats. Canadian Journal of veterinary Research 84 (1): 60-66. 

14- Pinello, K.C, Queiroga, F., de Matos, A., Santos, A., Ribeiro, J.N., Guscetti, F., Palmieri, C., Momanyi, K., Torres, JR, Killick, D., Radford, A., Wilson-Robles, H., Carvalho, JP, Tedardi, MV, Dagli, ML (2020). The Global Initiative for Veterinary Cancer Surveillance (GIVCS): Report of the first meeting and future perspectives. Veterinary Comparative Oncology 1-2. DOI: 10.1111/vco.12577

15 – Simões, PB, Costa, A, Santos, A, Marcos, R (2020). Blood from a “half-fish” dog: How modern analyzers deal with nucleated red blood cells. Veterinary Clinical Pathology 49:8-10. doi.org/10.1111/vcp.12844.

Abstracts publicados em congressos científicos internacionais

1 - Santos, A., Oliveira, J., Lopes, C., Vicente, C., Amorim, I., Gärtner, F., Matos, A., 2009. Immunohistochemical of VEGF in Canine Mammary Tumours. Abstracts from European Society of Veterinary Oncology Annual Congress, pp 7. Visegrád, Hungary, March 2009. 

2- Santos, A., Lopes, C., Amorim, I., Gärtner, F., Matos, A.J.F., 2009. Immunohistochemical expression of VEGF in canine mammary gland tumours and in regional and distant metastasis. Abstracts from 19th Congress of The European College of veterinary Internal Medicine - Companion Animals, pp 232. Porto, Portugal, September 2009.

3 - Santos, A., Lopes, C., Amorim, I., Frias, C., Vicente, C., Gärtner, F., Matos, A., 2010. Urokinase Plasminogen Activator protein expression and its prognostic value in canine mammary tumours. Abstracts from European Society of Veterinary Oncology Spring Congress, pp 26. Turin, Italy, March 2010.

4 - Santos, A., Lopes, C.C., Marques, R.M., Amorim, I., Frias, C., Gärtner, F., Matos, A.J.F., 2011. MMP-9 immunoexpression in canine mammary gland tumours: relationship with poor prognostic factors and patient’s outcome. Abstracts from European Society of Veterinary Oncology Annual Congress, pp 14. Glasgow, Sctoland, March 2011.

5 - Santos, A., Lopes, C., Frias, C., Gärtner, F., Matos, A., 2012. The prognostic value of VEGFR2 in female dogs with mammary gland tumours: a univariate survival study. Abstracts from 2nd World Veterinary Cancer Congress, pp 10. Paris, France, March 2012.

6- Ramos, S.C.M., Matos, A.J.F, Ribeiro, J.N., Martins, L.R.L, Ferreira, R.R.F, Santos, A.A. Serum levels of urokinase-type plasminogen activatorn canine patients with cancer. Abstracts from 3rd World Veterinary Cancer Congress, pp 65. Foz do Iguassu, Brasil, 2016.

7- Viegas, AC; Matos, AF; Ferreira, R; Villa Nova, M; Gregório, H; Martins, L., Santos, A. Determination and comparison of urokinase plasminogen activator serum levels among healthy cats and cats with oncologic disease. ESVONC congress 2017, pp 31 Lyon, France.

8- Batista, C., Santos, A., Villagrasa, M., Matos, A.J.F. Diagnostic imaging findings of uncommon sites for distant metastasis in canine mammary tumours. Abstracts from Annual Congress of the European Veterinary Diagnostic Imaging (EVDI), Vol. 55 Nº. 6 p. 668, Portugal, 2013.

9- Pinello, KC; Martins, L; Gregório, H; Santos, A; Queiroga, FL; Oliveira, F; Tedardi, MV; Dagli, ML; Niza-Ribeiro, J; de Matos, AJ. Implementation and preliminary results of an Animal Cancer Registry in Portugal (RCA-PT) in partnership with RCA-SP. ESVONC congress 2017, Lyon, France.

10 – Romão, R., Almeida, A.L., Santos, A., Lança, M.J. (2019). The evolution of practical veterinary anatomy teaching in the University of Évora – the use of cadavers: privilege or triviality? Poster in the I International Congress of Education in Animal Sciences (ICEAS), Évora, Portugal.